Biomarkers of drug-induced acute kidney injury in the adult

Bibliography

• Fanos V, Antonucci R, Zaffanelle M, et al. Neonatal drug induced nephrotoxicity: Old and next generation biomarkers for early detection and management of neonatal drug-induced nephrotoxicity, with special emphasis on NGAL and metabolomics. Curr Med Chem 2012;19:4595–605
   PubMed Web of Science ®Google Scholar
• Bellomo R, Kellum JA, Ronco C. Acute kidney injury. Lancet 2012;380:756–66
   PubMed Web of Science ®Google Scholar
• Endre ZH, Pickering JW, Walker RJ. Clearance and beyond: the complementary roles of GFR measurement and injury biomarkers in acute kidney injury (AKI). Am J Physiol Renal Physiol 2011;301:F697–707
   PubMed Web of Science ®Google Scholar
• Warnock DG, Muntner P, McCullough PA, et al. Kidney function, albuminuria, and 749 all-cause mortality in the REGARDS (Reasons for Geographic and Racial Differences 750 in Stroke) study. Am J Kidney Dis 2010;56:861–71
   PubMed Web of Science ®Google Scholar
• Schetz M, Dasta J, Goldstein S, et al. Drug-induced acute kidney injury. Curr Opin Crit Care 2005;11:555–65
   PubMed Web of Science ®Google Scholar
• Pannu N, Nadim MK. An overview of drug-induced acute kidney injury. Crit Care Med 2008;36(4 Suppl):S216–23
   PubMed Web of Science ®Google Scholar
• Jha V, Rathi M. Natural medicines causing acute kidney injury. Semin Nephrol 2008;28:416–28
   PubMed Web of Science ®Google Scholar
• Haase M, Kellum JA, Ronco C. Subclinical AKI - an emerging syndrome with important consequences. Nature Rev Nephrol 2012;8:735–9
   PubMed Web of Science ®Google Scholar
• Nejat M, Pickering J W, Devarajan P, et al. Some biomarkers of acute kidney injury are increased in pre-renal acute injury. Kidney Int 2012;81:1254–62
   PubMed Web of Science ®Google Scholar
• Bellomo R, Bagshaw S, Langenberg C, et al. Pre-renal azotemia: a flawed paradigm in critically ill septic patients? Contrib Nephrol 2007;156:1–9
   PubMed Web of Science ®Google Scholar
• Endre ZH, Kellum J A, Di Somma S, et al. Differential diagnosis of AKI in clinical practice by functional and damage biomarkers: workgroup statements from the tenth Acute Dialysis Quality Initiative Consensus Conference. Contrib Nephrol 2013;182:30–44
   PubMed Web of Science ®Google Scholar
• Pianta TJ, Buckley NA, Peake PW, et al. Clinical use of biomarkers for toxicant-induced acute kidney injury. Biomarkers Med 2013;7:441–56
   PubMed Web of Science ®Google Scholar
• Uchino S, Bellomo R, Goldsmith D, et al. An assessment of the RIFLE criteria for acute renal failure in hospitalized patients. Crit Care Med 2006;34:1913–17
   PubMed Web of Science ®Google Scholar
• Chertow GM, Burdick E, Honour M, et al. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol 2005;16:3365–70
   PubMed Web of Science ®Google Scholar
• Coca SG, Yusuf B, Shlipak MG, et al. Long-term risk of mortality and other adverse outcomes after acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis 2009;53:961–73
   PubMed Web of Science ®Google Scholar
• Lu R, Mucino-Bermejo MJ, Armignacco P, et al. Survey of acute kidney injury and related risk factors of mortality in hospitalized patients in a third-level urban hospital of Shanghai. Blood Purif 2014;38:140–8
   PubMed Web of Science ®Google Scholar
• Bonventre JV, Yang L. Cellular pathophysiology of ischemic acute kidney injury. J Clin Invest 2011;121:4210–21
   PubMed Web of Science ®Google Scholar
• Mehta RL, Kellum JA, Shah SV, et al. Acute kidney injury network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007;11:R31
   PubMed Web of Science ®Google Scholar
• KDIGO. Section 2: AKI Definition. Kidney Int 2012;2(Suppl 1):7–24
   Google Scholar
• Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Practice 2012;120:c179–84
   PubMed Web of Science ®Google Scholar
• Ronco C, Legrand M, Goldstein SL, et al. Neutrophil gelatinase-associated lipocalin: ready for routine clinical use? An international perspective. Blood Purif 2014;37:271–85
   PubMed Web of Science ®Google Scholar
• Westhuyzen J, Endre Z H, Reece G, et al. Measurement of tubular enzymuria facilitates early detection of acute renal impairment in the intensive care unit. Nephrol Dial Transplant 2003;18:543–51
   PubMed Web of Science ®Google Scholar
• Han WK, Bailly V, Abichandani R, et al. Kidney injury molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury. Kidney Int 2002;62:237–44
   PubMed Web of Science ®Google Scholar
• Endre ZH, Westhuyzen J. Early detection of acute kidney injury: emerging new biomarkers. Nephrology (Carlton) 2008;13:91–8
   PubMed Web of Science ®Google Scholar
• Huang YC, Wu YL, Lee MH, et al. Association of renal biomarkers with 3-month and 1-year outcomes among critically ill acute stroke patients. PLoS One 2013;8:e72971
   PubMedGoogle Scholar
• Hingorani S, Molitoris BA, Himmelfarb J. Ironing out the pathogenesis of acute kidney injury. Am J Kidney Dis 2009;53:569–71
   PubMed Web of Science ®Google Scholar
• Dieterle F, Sistare F, Goodsaid F, et al. Renal biomarker qualification submission: a dialog between the FDA-EMEA and predictive safety testing consortium. Nat Biotechnol 2010;28:455–62
   PubMed Web of Science ®Google Scholar
• Rouse RL, Zhang J, Stewart SR, et al. Comparative profile of commercially available urinary biomarkers in preclinical drug-induced kidney injury and recovery in rats. Kidney Int 2011;79:1186–97
   PubMed Web of Science ®Google Scholar
• Bonventre JV. Kidney injury molecule-1 (KIM-1): a specific and sensitive biomarker of kidney injury. Scand J Clin Lab Invest Suppl 2008;241:78–83
   PubMedGoogle Scholar
• Mishra J, Ma Q, Prada A, et al. Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J Am Soc Nephrol 2003;14:2534–43
   PubMed Web of Science ®Google Scholar
• Haase M, Bellomo R, Devarajan P, et al. Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis 2009;54:1012–24
   PubMed Web of Science ®Google Scholar
• Kashani K, Al-Khafaji A, Ardiles T, et al. Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. Crit Care 2013;7:R25
   Google Scholar
• Endre ZH, Pickering JW. Acute kidney injury: Cell cycle arrest biomarkers win race for AKI diagnosis. Nature Rev Nephrol 2014;10:683–5
   PubMed Web of Science ®Google Scholar
• Bihorac A, Chawla LS, Shaw AD, et al. Validation of cell-cycle arrest biomarkers for acute kidney injury using clinical adjudication. Am J Respir Crit Care Med 2014;189:932–9
   PubMed Web of Science ®Google Scholar
• Fassett RG, Venuthurupalli SK, Gobe GC, et al. Biomarkers in chronic kidney disease: a review. Kidney Int 2011;80:806–21
   PubMed Web of Science ®Google Scholar
• Endre ZH. Novel biomarkers of acute kidney injury: time for implementation? Biomarkers Med 2014;8:1185–8
   PubMed Web of Science ®Google Scholar
• Endre ZH. Recovery from acute kidney injury: the role of biomarkers. Nephron Clin Pract 2014;127:101–5
   PubMed Web of Science ®Google Scholar
• Koyner JL, Shaw AD, Chawla LS, et al. Tissue Inhibitor Metalloproteinase-2 (TIMP-2)-IGF-Binding Protein-7 (IGFBP7) Levels Are Associated with Adverse Long-Term Outcomes in Patients with AKI. J Am Soc Nephrol 2015;26(7):1747–54
   PubMed Web of Science ®Google Scholar
• Price P M, Safirstein R L, Megyesi J. The cell cycle and acute kidney injury. Kidney Int 2009;76:604–13
   PubMed Web of Science ®Google Scholar
• Gobe GC, Endre ZH. Cell death in toxic nephropathies. Semin Nephrol 2003;23:416–24
   PubMed Web of Science ®Google Scholar
• Vaidya VS, Waikar SS, Ferguson MA, et al. Urinary biomarkers for sensitive and specific detection of acute kidney injury in humans. Clin Transl Sci 2008;1:200–8
   PubMed Web of Science ®Google Scholar
• Basu RK, Wong HR, Krawczeski CD, et al. Combining functional and tubular damage biomarkers improves diagnostic precision for acute kidney injury after cardiac surgery. J Am Coll Cardiol 2014;64:2753–62
   PubMed Web of Science ®Google Scholar
• Murray PT, Mehta RL, Shaw A, et al. ADQI 10 workgroup. Potential use of biomarkers in acute kidney injury: report and summary of recommendations from the 10th acute dialysis quality initiative consensus conference. Kidney Int 2014;85:513–21
   PubMed Web of Science ®Google Scholar
• Faull R. Prescribing in renal disease. Australian Prescriber 2007;30:17–20
   Google Scholar
• Nejat M, Hill JV, Pickering JW, et al. Albuminuria increases cystatin C excretion: implications for urinary biomarkers. Nephrol Dial Transplant 2011(Suppl 3):iii96–103
   PubMedGoogle Scholar
• Briggs JP. The hunt for the perfect biomarker for acute kidney injury: back to gamma-trace? Kidney Int 2008;74:987–9
   PubMed Web of Science ®Google Scholar
• Dieterle F, Perentes E, Cordier A, et al. Urinary clusterin, cystatin C, β2-microglobulin and total protein as markers to detect drug-induced kidney injury. Nat Biotechnol 2010;28:463–9
   PubMed Web of Science ®Google Scholar
• Soto K, Coelho S, Rodrigues B, et al. Cystatin C as a marker of acute kidney injury in the emergency department. Clin J Am Soc Nephrol 2010;5:1745–54
   PubMed Web of Science ®Google Scholar
• Miyata T, Jadoul M, Kurokawa K et al. Beta-2 microglobulin in renal disease. J Am Soc Nephrol 1998;9:1723–35
   PubMed Web of Science ®Google Scholar
• Vaidya VS, Ozer JS, Dieterle F, et al. Kidney injury molecule-1 outperforms traditional biomarkers of kidney injury in preclinical biomarker qualification studies. Nat Biotechnol 2010;28:478–85
   PubMed Web of Science ®Google Scholar
• Tolkoff-Rubin NE, Rubin RH, Bonventre JV. Noninvasive renal diagnostic studies. Clin Lab Med 1988;8:507–26
   PubMed Web of Science ®Google Scholar
• Emeigh Hart SG. Assessment of renal injury in vivo. J Pharmacol Toxicol Methods 2005;52:30–45
   PubMedGoogle Scholar
• Wolf MW, Boldt J. Kidney specific proteins: markers for detection of renal dysfunction after cardiac surgery? Clin Res Cardiol Suppl 2007;2:S103–7
   Google Scholar
• Russo LM, Sandoval RM, McKee M, et al. The normal kidney filters nephrotic levels of albumin retrieved by proximal tubule cells: retrieval is disrupted in nephrotic states. Kidney Int 2007;71:504–13
   PubMed Web of Science ®Google Scholar
• Koch Nogueira PC, Hadj-Aïssa A, Schell M, et al. Long-term nephrotoxicity of cisplatin, ifosfamide, and methotrexate in osteosarcoma. Pediatr Nephrol 1998;12:572–5
   PubMed Web of Science ®Google Scholar
• Kern W, Braess J, Kaufmann CC, et al. Microalbuminuria during cisplatin therapy: relation with pharmacokinetics and implications for nephroprotection. Anticancer Res 2000;20:3679–88
   PubMed Web of Science ®Google Scholar
• Tugay S, Bircan Z, Cağlayan C, et al. Acute effects of gentamicin on glomerular and tubular functions in preterm neonates. Pediatr Nephrol 2006;21:1389–92
   PubMed Web of Science ®Google Scholar
• Goetz DH, Willie ST, Armen RS, et al. Ligand preference inferred from the structure of neutrophil gelatinase associated lipocalin. Biochemistry 2000;39:1935–41
   PubMed Web of Science ®Google Scholar
• Mishra J, Mori K, Ma Q, et al. Neutrophil gelatinase-associated lipocalin: a novel early urinary biomarker for cisplatin nephrotoxicity. Am J Nephrol 2004;24:307–15
   PubMed Web of Science ®Google Scholar
• Nickolas TL, O’Rourke MJ, Yang J, et al. Sensitivity and specificity of a single emergency department measurement of urinary neutrophil gelatinase-associated lipocalin for diagnosing acute kidney injury. Ann Intern Med 2008;148:810–19
   PubMed Web of Science ®Google Scholar
• Cruz DN, de Cal M, Garzotto F, et al. Plasma neutrophil gelatinase-associated lipocalin is an early biomarker for acute kidney injury in an adult ICU population. Intensive Care Med 2009;36:444–51
   PubMed Web of Science ®Google Scholar
• Constantin JM, Futier E, Perbet S, et al. Plasma neutrophil gelatinase-associated lipocalin is an early marker of acute kidney injury in adult critically ill patients: a prospective study. J Crit Care 2010;25:171–6
   Web of Science ®Google Scholar
• Ronco C, Cruz D, Noland BW. Neutrophil gelatinase-associated lipocalin curve and neutrophil gelatinase-associated lipocalin extended-range assay: a new biomarker approach in the early diagnosis of acute kidney injury and cardio-renal syndrome. Semin Nephrol 2012;32:121–8
   PubMed Web of Science ®Google Scholar
• Bachorzewska-Gajewska H, Malyszko J, Sitniewska E, et al. Neutrophil-gelatinase-associated lipocalin and renal function after percutaneous coronary interventions. Am J Nephrol 2006;26:287–92
   PubMed Web of Science ®Google Scholar
• Ling W, Zhaohui N, Ben H, et al. Urinary IL-18 and NGAL as early predictive biomarkers in contrast-induced nephropathy after coronary angiography. Nephron Clin Pract 2008;108:c176–81
   PubMed Web of Science ®Google Scholar
• Bagshaw SM, Bennett M, Haase M, et al. Plasma and urine neutrophil gelatinase-associated lipocalin in septic versus non-septic acute kidney injury in critical illness. Intensive Care Med 2010;36:452–61
   PubMed Web of Science ®Google Scholar
• Bolignano D, Lacquaniti A, Coppolino G, et al. Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney disease. Clin J Am Soc Nephrol 2009;4:337–44
   PubMed Web of Science ®Google Scholar
• Ko GJ, Grigoryev DN, Linfert D, et al. Transcriptional analysis of kidneys during repair from AKI reveals possible roles for NGAL and KIM-1 as biomarkers of AKI to CKD transition. Am J Physiol Renal Physiol 2010;298:F1472–83
   PubMed Web of Science ®Google Scholar
• Ichimura T, Bonventre JV, Bailly V, et al. Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury. J Biol Chem 1998;273:4135–42
   PubMed Web of Science ®Google Scholar
• Fuchs TC, Hewitt P. Biomarkers for drug-induced renal damage and nephrotoxicity-an overview for applied toxicology. AAPS J 2011;13:615–23
   PubMed Web of Science ®Google Scholar
• Vaidya VS, Ozer JS, Dieterle F, et al. Kidney injury molecule-1 outperforms traditional biomarkers of kidney injury in preclinical biomarker qualification studies. Nat Biotechnol 2010;28:478–85
   PubMed Web of Science ®Google Scholar
• Wunnapuk K, Gobe G, Endre Z, et al. Use of a glyphosate-based herbicide-induced nephrotoxicity model to investigate a panel of kidney injury biomarkers. Toxicol Lett 2014;225:192–200
   PubMed Web of Science ®Google Scholar
• Sinha V, Vence LM, Salahudeen AK. Urinary tubular protein-based biomarkers in the rodent model of cisplatin nephrotoxicity: a comparative analysis of serum creatinine, renal histology, and urinary KIM-1, NGAL, and NAG in the initiation, maintenance, and recovery phases of acute kidney injury. J Investig Med 2013;61:564–8
   PubMed Web of Science ®Google Scholar
• Ferguson A, Vaidya V, Bonventre JV. Biomarkers of nephrotoxic acute kidney injury. Toxicology 2008;245:182–93
   PubMed Web of Science ®Google Scholar
• Racine SX, Le Toumelin P, Adnet F, et al. N-acetyl functions and acetate detected by nuclear magnetic resonance spectroscopy of urine to detect renal dysfunction following aminoglycoside and/or glycopeptide antibiotic therapy. Nephron Physiol 2004;97:53–7
   Google Scholar
• Lee DH, Jacobs DRJr, Gross M, et al. Serum gamma-glutamyltransferase was differently associated with microalbuminuria by status of hypertension or diabetes: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Clin Chem 2005;51:1185–91
   PubMed Web of Science ®Google Scholar
• Yu Y, Jin H, Holder D, et al. Urinary biomarkers trefoil factor 3 and albumin enable early detection of kidney tubular injury. Nat Biotech 2010;28:470–7TFF3
   PubMed Web of Science ®Google Scholar
• Tan F, Chen Y, Yuan D, et al. Dexmedetomidine protects against acute kidney injury through downregulating inflammatory reactions in endotoxemia rats. Biomed Rep 2015;3:365–70
   PubMed Web of Science ®Google Scholar
• Nisula S, Yang R, Poukkanen M, et al. Predictive value of urine interleukin-18 in the evolution and outcome of acute kidney injury in critically ill adult patients. Br J Anaesth 2015;114:460–8
   PubMed Web of Science ®Google Scholar
• Dennen P, Altmann C, Kaufman J, et al. Urine interleukin-6 is an early biomarker of acute kidney injury in children undergoing cardiac surgery. Crit Care 2010;14:R1812010–IL6
   Google Scholar
• Ferguson MA, Vaidya VS, Waikar SS, et al. Urinary liver-type fatty acid-binding protein predicts adverse outcomes in acute kidney injury. Kidney Int 2010;77:708–14
   PubMed Web of Science ®Google Scholar
• Rosenberg ME, Paller MS. Differential gene expression in the recovery from ischemic renal injury. Kidney Int 1991;39:1156–61
   PubMed Web of Science ®Google Scholar
• Witzgall R, Brown D, Schwarz C, et al. Localization of proliferating cell nuclear antigen, vimentin, c-Fos, and clusterin in the post-ischemic kidney. Evidence for a heterogenous genetic response among nephron segments, and a large pool of mitotically-active and dedifferentiated cells. J Clin Invest 1994;93:2175–88
   PubMed Web of Science ®Google Scholar
• Gobe GC, Buttyan R, Wyburn KR, et al. Clusterin expression and apoptosis in tissue remodeling associated with renal regeneration. Kidney Int 1995;47:411–20
   PubMed Web of Science ®Google Scholar
• Pianta TJ, Peake PW, Pickering JW, et al. Clusterin in kidney transplantation: novel biomarkers versus serum creatinine for early prediction of delayed graft function. Transplantation 2015;99:171–9
   PubMed Web of Science ®Google Scholar
• Aulitzky WK, Schlegel PN, Wu DF, et al. Measurement of urinary clusterin as an index of nephrotoxicity. Proc Soc Exp Biol Med 1992;199:93–6
   PubMed Web of Science ®Google Scholar
• Silkensen JR, Agarwal A, Nath KA, et al. Temporal induction of clusterin in cisplatin nephrotoxicity. J Am Soc Nephrol 1997;8:302–5
   PubMed Web of Science ®Google Scholar
• Gobe G, Zhang XJ, Willgoss DA, et al. Relationship between expression of Bcl-2 genes and growth factors in ischemic acute renal failure in the rat. J Am Soc Nephrol 2000;11:454–67
   PubMed Web of Science ®Google Scholar
• Kilany A, Raouf ER, Gaber AA, et al. Elevated serum Bcl-2 in children with temporal lobe epilepsy. Seizure 2012;21:250–3
   PubMed Web of Science ®Google Scholar
• Fathi NA, Hussein MR, Hassan HI, et al. Glomerular expression and elevated serum Bcl-2 and Fas proteins in lupus nephritis: preliminary findings. Clin Exp Immunol 2006;146:339–43
   PubMed Web of Science ®Google Scholar
• Mariano F, Cantaluppi V, Stella M, et al. Circulating plasma factors induce tubular and glomerular alterations in septic burns patients. Crit Care 2008;12:R42
   PubMed Web of Science ®Google Scholar
• Strobel NA, Fassett RG, Marsh SA, et al. Importance of understanding pre-analytical variability in biomarker development. Int J Cardiol 2011;150:223–4
   PubMed Web of Science ®Google Scholar
• Haase M, Mertens PR. Biomarkers: more than just markers. Nephrol Dial Transplant 2015;30:33–8
   PubMed Web of Science ®Google Scholar
• Ostermann M, Philips BJ, Forni LG. Clinical review: Biomarkers of acute kidney injury: where are we now. Crit Care 2012;16:233
   PubMed Web of Science ®Google Scholar
• Mussap M, Noto A, Fanos V, et al. Emerging biomarkers and metabolomics for assessing toxic nephropathy and acute kidney injury (AKI) in neonatology. BioMed Res Int 2014;2014:602526
   PubMed Web of Science ®Google Scholar
• Fanos V, Fanni C, Ottonello G, et al. Metabolomics in adult and pediatric nephrology. Molecules 2013;18:4844–57
   PubMed Web of Science ®Google Scholar